RECENT NEWS

October 9, 2008

Synageva Biopharma Appoints Leading Clinician and Industry Executive, Dr. Mark Goldberg, to its Board of Directors.

September 1, 2008

Synageva Biopharma appoints Sanj K. Patel president and chief executive officer and opens new corporate headquarters

UPCOMING EVENTS

BIO Investor Forum

October 29-31, 2008
San Francisco, CA

JPMorgan Healthcare Conference

January 12-15, 2009
San Francisco, CA




Synageva BioPharma is focused on the development of biopharmaceuticals that address the needs of a global patient population in multiple areas, including oncology, autoimmune diseases and genetic diseases.

SynagevaTM has created sustainable value through its robust and cost-effective protein expression technology, AESTM. We have generated a diverse pipeline of follow-on products as well as next-generation products that may exhibit superior efficacy and safety profiles. In addition we have targeted research programs focused on novel products for areas of high unmet medical need.



Patient Information